Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The geriatrics and genetics behind bladder cancer.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting - 1 Jan 2014

Milowsky Matthew I, Kim William Y

Abstract excerpt

Bladder cancer is a disease of older patients who often have multiple comorbidities. Although cisplatin-based combination chemotherapy is the standard of care in the neoadjuvant and metastatic settings, outcomes remain poor, and approximately half of patients are ineligible for cisplatin where treatment options are severely limited. Recent comprehensive genome sequencing studies have defined the mutational...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Transitional Cell

Share to Chromatin Assembly and Disassembly

Share to Molecular Targeted Therapy

Share to Mutation

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 24857102
DOI: 10.14694/EdBook_AM.2014.34.e192

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The geriatrics and genetics behind bladder cancer.PMID 24857102Read ↗

Similar genetic profile in early and late stage urothelial tract cancer.Semantic proximity Read ↗

Clinical and genomic profiling of early-onset bladder cancer identifies key alterations and therapeutic targetsSemantic proximity Read ↗

Genetic characteristics and targeted treatments of primary bladder and urachal adenocarcinomas: a systematic review with pooled descriptive genomic analyses.Semantic proximity Read ↗

The Cancer Genome Atlas Project in Bladder Cancer.Semantic proximity Read ↗

The Evolving Molecular Landscape and Actionable Alterations in Urologic Cancers.Semantic proximity Read ↗

Genetic alterations and biological pathways in human bladder cancer pathogenesisSemantic proximity Read ↗

Genetic and Epigenetic Alterations in Bladder CancerSemantic proximity Read ↗

Molecular genetics of bladder cancer: pathways of development and progression.Semantic proximity Read ↗

Beyond driver mutations: exploring the landscape of mutational signatures in adenocarcinomas of the bladder†.Semantic proximity Read ↗

Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancerSemantic proximity Read ↗

Bladder Cancer in the Genomic EraSemantic proximity Read ↗

Molecular Profiling of Bladder Adenocarcinoma Using a National Genomics RepositorySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.